Skip to content
Governance Register

← US public companies

Omega Therapeutics, Inc.

SEC CIK 1850838 · OMGA · last insider filing 2025-02-04

Directors (from insider filings)

NameCapacity as filedFilings
Varsalone Jeffrey T Director filed 2025 - 2025
Mehrotra Ravi Director filed 2024 - 2024
Certel Kaan Director · See Remarks filed 2024 - 2024
Rosiello Robert L. Director filed 2024 - 2024
Schade Christian S Director filed 2023 - 2024
Mendlein John Director filed 2021 - 2024
Kender Richard N Director filed 2024 - 2024
Szela Mary T Director filed 2021 - 2024
Young Richard A Director filed 2021 - 2024
Boehm Rainer J. Director filed 2022 - 2024
Levy Elliott M. Director filed 2021 - 2024
Werner Michelle C Director filed 2023 - 2024
Karande Mahesh Director · President and CEO filed 2021 - 2024
Beshar Luke M Director filed 2021 - 2023
Afeyan Noubar Director filed 2021 - 2023
Flagship Ventures Management, Inc. Director filed 2021 - 2023
Berry David A Director filed 2021 - 2021

Officers (from insider filings)

NameTitle as filedFilings
Nelson Jennifer Ann Chief Scientific Officer filed 2024 - 2024
Chan Barbara Y Chief Accounting Officer filed 2024 - 2024
Reed Joshua Chief Financial Officer filed 2022 - 2024
Zeng Ling See Remarks filed 2022 - 2024
Mccauley Thomas Chief Scientific Officer filed 2021 - 2024
Moore Yan Chief Medical Officer filed 2022 - 2024
Mcmanus Kevin Chief Human Resources Officer filed 2022 - 2023
Sawhney Roger Chief Financial Officer filed 2021 - 2022

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.